Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Triadafilopoulos, G; Taddei, A; Bechi, P; Freschi, G; Ringressi, MN; Degli'innocenti, DR; Castiglione, F; Masini, E; Majewski, M; Wallner, G; Sarosiek, J; Dillon, JF; McCallum, RC; Dvorak, K; Goldman, A; Woodland, P; Sifrim, D; Richter, JE; Vieth, M; Neumann, H; Langner, C; Ishimura, N; Amano, Y; Felix, VN.
Barrett's esophagus: proton pump inhibitors and chemoprevention I.
Ann N Y Acad Sci. 2011; 1232(1): 93-113.
Doi: 10.1111/j.1749-6632.2011.06047.x
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Langner Cord
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The following on proton pump inhibitors and chemoprevention in Barrett's esophagus includes commentaries on normalization of esophageal refluxate; the effects of 5-HT(4) agonists on EGF secretion and of lubripristone on chloride channels agents; the role of Campylobacter toxin production; the deleterious effects of unconjugated bile acids; the role of baclofen in nonacid reflux; the threshold for adequate esophageal acid exposure; the effects of proton pump inhibitor (PPI) therapy on normalization of esophageal pH and on cell proliferation; the role of the phenotype of cellular proliferation on the effects of PPI therapy; and the value of Symptom Index and Symptom Association Probability in the evaluation of potential response to treatment.
- Find related publications in this database (using NLM MeSH Indexing)
-
Barrett Esophagus - drug therapy
-
Chemoprevention -
-
Humans -
-
Proton Pump Inhibitors - therapeutic use
- Find related publications in this database (Keywords)
-
Barrett's treatment
-
omeprazole
-
duodenogastroesophageal reflux
-
dysplasia
-
Symptom Sensitivity Index
-
Symptom Association Probability
-
antireflux surgery
-
PPI
-
mucin phenotype
-
pH control
-
esomeprazole
-
basal cell layer
-
hyperplasia
-
stromal papillae
-
GABA(B) baclofen
-
lesogaberan
-
weakly acidic reflux
-
TLESR
-
Campylobacter
-
microbiota
-
prostone
-
5-HT4
-
TGF-alpha
-
GERD
-
EGF
-
mucosal protection
-
CDX2
-
Barrett's cell lines